|
Genpharmasec Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
107.42 Cr.
|
P/BV
|
1.64
|
Book Value (Rs.)
|
1.18
|
|
52 Week High/Low (Rs.)
|
4/2
|
FV/ML
|
1/1
|
P/E(X)
|
87.39
|
|
Bookclosure
|
23/07/2024
|
EPS (Rs.)
|
0.02
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR |
| FaceValue | 1.00 | 1.00 |
| | | |
| PER SHARE RATIOS | | |
| | | |
| Basic EPS (Rs.) | 0.01 | -0.01 |
| Diluted EPS (Rs.) | 0.01 | -0.01 |
| Cash EPS (Rs.) | 0.03 | 0.00 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 1.18 | 1.17 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 1.18 | 1.17 |
| Revenue From Operations / Share (Rs.) | 0.60 | 0.54 |
| PBDIT / Share (Rs.) | 0.05 | 0.01 |
| PBIT / Share (Rs.) | 0.04 | 0.01 |
| PBT / Share (Rs.) | 0.03 | 0.00 |
| Net Profit / Share (Rs.) | 0.02 | 0.00 |
| NP After MI And SOA / Share (Rs.) | 0.02 | 0.00 |
| | | |
| PROFITABILITY RATIOS | | |
| | | |
| PBDIT Margin (%) | 9.27 | 2.30 |
| PBIT Margin (%) | 6.86 | 2.16 |
| PBT Margin (%) | 5.57 | 0.82 |
| Net Profit Margin (%) | 3.65 | -0.55 |
| NP After MI And SOA Margin (%) | 3.65 | -0.41 |
| Return on Networth / Equity (%) | 1.88 | -0.19 |
| Return on Capital Employeed (%) | 3.30 | 0.96 |
| Return On Assets (%) | 1.54 | -0.17 |
| Long Term Debt / Equity (X) | 0.04 | 0.04 |
| Total Debt / Equity (X) | 0.04 | 0.04 |
| Asset Turnover Ratio (%) | 0.44 | 0.00 |
| | | |
| LIQUIDITY RATIOS | | |
| | | |
| Current Ratio (X) | 2.86 | 15.16 |
| Quick Ratio (X) | 2.03 | 11.89 |
| Inventory Turnover Ratio (X) | 0.10 | 0.00 |
| | | |
| COVERAGE RATIOS | | |
| | | |
| Interest Coverage Ratio (%) | 7.19 | 1.72 |
| Interest Coverage Ratio (Post Tax) (%) | 3.83 | 0.58 |
| | | |
| VALUATION RATIOS | | |
| | | |
| Enterprise Value (Cr.) | 102.65 | 108.00 |
| EV / Net Operating Revenue (X) | 3.04 | 3.55 |
| EV / EBITDA (X) | 32.83 | 153.89 |
| MarketCap / Net Operating Revenue (X) | 3.10 | 4.06 |
| Price / BV (X) | 1.61 | 1.92 |
| Price / Net Operating Revenue (X) | 3.10 | 4.06 |
| EarningsYield | 0.01 | 0.00 |
